NCT05384015 2025-04-10
PEERS
Fundación GECP
Phase 2 Recruiting
Clinical Trials
3 trialsNCT01877083 2019-08-13
Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung
Eisai Inc.
Phase 2 Completed
NCT00832819 2015-04-30
E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC)
Eisai Inc.
Phase 1 Completed